David Alan Caldwell - 30 Jan 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP - Strategy & Corp Dev
Signature
Jonathan Leiken, Attorney-in-fact for David Alan Caldwell
Issuer symbol
DBD
Transactions as of
30 Jan 2023
Transactions value $
-$8,604
Form type
4
Filing time
01 Feb 2023, 17:03:59 UTC
Previous filing
19 Aug 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability -$8.6K -3.74K -1.71% $2.30* 215K 30 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 9.35K 30 Jan 2023 Common Shares 9.35K $11.96 Direct F3
holding DBD Non-Qualified Stock Option 33.9K 30 Jan 2023 Common Shares 33.9K $4.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.